Pressegespräch mit Nationalratspräsident Sobotka, ÖAW-Präsident Zeilinger und WissenschaftlerInnen
HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, announced today its Board of Directors has appointed Wayne Barr, Jr. as
Repligen develops and sells bioprocessing technologies and systems involved in the manufacturing of biological drugs. The company operates within a high growth,
Die Comics richten sich an 7- bis 10-jährige Kids. Die besten Wettbewerbsbeiträge werden mit 12.000 Euro prämiert.
Becton, Dickinson reported its fiscal Q2 earnings in May which beat expectations while noting significant disruptions amid the COVID-19 pandemic. A slowdown in
IBM (NYSE:IBM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports. The brokerage presently has a $140.00
RWS (LON:RWS) had its price target decreased by investment analysts at Barclays from GBX 630 ($8.02) to GBX 610 ($7.76) in a research report issued on Wednesday, ThisIsMoney.Co.Uk reports. The firm pr
BlackRock Inc. raised its holdings in shares of Kezar Life Sciences Inc (NASDAQ:KZR) by 97.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional
Three proven multi-tenant data centers have been brought together as a single-service entity by DataBridge Sites, offering cloud, colocation, and inte

Why Kezar Life Sciences Is Down Today

08:15pm, Tuesday, 09'th Jun 2020
Shares of Kezar Life Sciences (NASDAQ: KZR) are down by 11.7% as of 3:12 p.m. EDT on Tuesday, following the company's announcement of the pricing of a public offering of common stock. Kezar Life Scie
Phreesia, Inc. (NYSE:PHR) Q1 2021 Earnings Conference Call June 09, 2020 08:30 A.M. ET Company Participants Balaji Gandhi - VP, IR Chaim Indig - CEO Thomas Alti

Is This Flaming Hot Biotech Stock a Buy?

03:15pm, Tuesday, 09'th Jun 2020
Kezar Life Sciences just released interim results on its only drug and shares jumped 70%. Now that the stock has settled, is it a good time to buy?
The public offering price of each share of common stock is $5.50 and the public offering price of each pre-funded warrant is $5.499 per underlying share. In addition, Kezar has granted the underwrite
Zcube has launched the fourth edition of Open Accelerator, the international acceleration programme dedicated to startups in Life Sciences
NeoGenomics runs a network of cancer-testing laboratories across the US, Switzerland and Singapore. The company offers a unique combination of services and prod
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE